Richard G. Bach, MD; Christopher P. Cannon, MD; Robert P. Giugliano, MD, SM; et al.
free access
has audio
JAMA Cardiol. 2019;4(9):846-854. doi:10.1001/jamacardio.2019.2306
This prespecified secondary analysis of a randomized clinical trial assesses the effect on outcomes and risks of ezetimibe plus simvastatin vs simvastatin alone as a higher-intensity treatment to lower lipid levels in elderly patients after acute coronary syndrome.
-
Audio Author Interview:
Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy Among Patients 75 Years or Older
-
Invited Commentary
Intensive Lipid Lowering in Elderly Patients
Antonio M. Gotto Jr, MD, DPhil
JAMA Cardiol
-
Audio Author Interview:
Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy Among Patients 75 Years or Older
DEFINE-FLAIR Trial Investigators
free access
JAMA Cardiol. 2019;4(9):857-864. doi:10.1001/jamacardio.2019.2298
This secondary analysis of the Functional Lesion Assessment of Intermediate stenosis to Guide Revascularization (DEFINE-FLAIR) randomized clinical trial compares 1-year clinical outcomes of fractional flow reserve or instantaneous wave-free ratio treatment in patients with and without diabetes.
Vera Bittner, MD, MSPH; Lisandro D. Colantonio, MD, PhD; Yuling Dai, MS, MSPH; et al.
free access
JAMA Cardiol. 2019;4(9):865-872. doi:10.1001/jamacardio.2019.2481
This cohort analysis explores the relative strength of associations of region and hospital and patient characteristics with high-intensity statin use after myocardial infarction in a population of fee-for-service US Medicare beneficiaries.
Tiange Wang, MD, PhD; Jieli Lu, MD, PhD; Qing Su, MD, PhD; et al.
free access
JAMA Cardiol. 2019;4(9):874-883. doi:10.1001/jamacardio.2019.2499
This study investigates the associations of ideal cardiovascular health metrics with subsequent development of cardiovascular disease among participants with prediabetes or diabetes compared with Chinese adults with normal glucose regulation.
Youssef A. Elnabawi, MD; Evangelos K. Oikonomou, MD; Amit K. Dey, MD; et al.
free access
JAMA Cardiol. 2019;4(9):885-891. doi:10.1001/jamacardio.2019.2589
This cohort study investigates the association of biologic therapy with coronary inflammation in patients with psoriasis as assessed by the perivascular fat attenuation index, an imaging biomarker that assesses coronary inflammation by mapping spatial changes of perivascular fat composition via coronary computed tomography angiography.
Francesco Santoro, MD, PhD; Iván J. Núñez Gil, MD, PhD, FESC; Thomas Stiermaier, MD; et al.
free access
JAMA Cardiol. 2019;4(9):892-899. doi:10.1001/jamacardio.2019.2597
This prognostic study of 1007 patients uses the German and Italian Stress Cardiomyopathy (GEIST) registry to develop a clinical prognostic score to stratify the risk for in-hospital complications among patients with takotsubo syndrome at hospital admission.
Sue Duval, PhD; Paul E. Pepe, MD, MPH; Tom P. Aufderheide, MD, MS; et al.
open access
JAMA Cardiol. 2019;4(9):900-908. doi:10.1001/jamacardio.2019.2717
This cohort study of data from the National Institutes of Health clinical trials network database assesses the optimal chest compression rate and depth associated with improved survival after out-of-hospital cardiac arrest and examines whether favorable survival varies by age, sex, cardiac rhythm, or cardiopulmonary resuscitation adjunct use.
Yuichiro Yano, MD, PhD; Rikki M. Tanner, PhD; Swati Sakhuja, MPH; et al.
free access
JAMA Cardiol. 2019;4(9):910-917. doi:10.1001/jamacardio.2019.2845
This cohort study examines whether daytime and nighttime blood pressure levels measured outside the clinic vs inside the clinic are associated with cardiovascular disease and all-cause mortality.
Gabrielle Norrish, BMBCh; Tao Ding, PhD; Ella Field, BA; et al.
free access
JAMA Cardiol. 2019;4(9):918-927. doi:10.1001/jamacardio.2019.2861
This cohort study develops a model to use in risk stratification for sudden cardiac death in children with hypertrophic cardiomyopathy.
Erin A. Bohula, MD, DPhil; Jason N. Katz, MD, MHS; Sean van Diepen, MD, MSc; et al.
free access
JAMA Cardiol. 2019;4(9):928-935. doi:10.1001/jamacardio.2019.2467
This study characterizes patients admitted to US cardiac intensive care units within the Critical Care Cardiology Trials Network.